Substituted thienopyrrole carboxylic acid amides, pyrrolothiazole carboxylic acid amides, and related analogs as inhibitors of casein kinase I epsilon

Details for Australian Patent Application No. 2005272584 (hide)

Owner Aventis Pharmaceuticals Inc

Inventors Collar, Nicola Dawn; Chiang, Yulin; Fink, David Marc

Agent Watermark

Pub. Number AU-B-2005272584

PCT Pub. Number WO2006/021000

Priority 60/603,347 19.08.04 US

Filing date 18 August 2005

Wipo publication date 23 February 2006

Acceptance publication date 11 November 2010

International Classifications

C07D 495/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms

A61K 31/425 (2006.01) - Thiazoles

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C07D 513/04 (2006.01) Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or

Event Publications

8 March 2007 PCT application entered the National Phase

  PCT publication WO2006/021000 Priority application(s): WO2006/021000

11 November 2010 Application Accepted

  Published as AU-B-2005272584

10 March 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005272585-Amphiphilic polynorbornene derivatives and methods of using the same

2005272579-Penetration improvement of copper amine solutions into dried wood by addition of carbon dioxide